2022-09 ESDR Abstr. No 610

Wolff-Winiski B, Schoefmann N, Doerfler P, Cabral G, Stuetz A. (2022)
Identification of the selective glucocorticoid receptor agonist Mapracorat as potential new drug for chronic wound therapy.
51st Annual ESDR Meeting, Sept. 28 – Oct. 1 2022, Amsterdam, The Netherlands
J Invest Dermatol 142 (12) Suppl S286 Abstr. No 610

2022-09 ESDR Abstr. No 602

Wolff-Winiski B, Doerfler P, Schoefmann N, Cabral G, Stuetz A. (2022)
Development of an assay platform for personalized treatment of chronic wounds.
51st Annual ESDR Meeting, Sept. 28 – Oct. 1 2022, Amsterdam, The Netherlands
J Invest Dermatol 142 (12) Suppl S286 Abstr. No 602

2022-05 EWMA

Schoefmann N, Doerfler P, Cabral G, Stuetz A, Wolff-Winiski B (2022)
Characterization of poly(ADP-ribose) polymerase (PARP) inhibitors as potential new drugs for chronic wound therapy.
EWMA-Journées Cicatrisations Meeting, May 23-25, 2022, Paris, France
J Wound Management 23 (1) S62 Abstr. No EP194

2021-10 EWMA transcriptomics poster

Cabral G, Doerfler P, Schoefmann N, Stuetz A, Wolff-Winiski B (2021)
Exposure of human dermal fibroblasts to chronic wound exudates triggers pro-inflammatory and anti-proliferative transcriptional changes.
Poster at the European Wound Management Association (EWMA), 26-27 October, 2021

2021-10 EWMA migration poster

Doerfler P, Stuetz A, Wolff-Winiski B (2021)
Development of a novel keratinocyte migration assay as a model for re-epithelialization of chronic wounds.
Poster at the European Wound Management Association (EWMA), 26-27 October, 2021

2017 ESDR

Doerfler P, Bauer W, Goerge T, Luger T, Rappersberger K, Stingl G, Stockinger T, Stuetz A, Wolff-Winiski B (2017)
Comparative analysis of cytokines, proteases and growth factors in human wound exudates obtained by vacuum therapy.
47th European Society Dermatological Research Meeting, 2017, Salzburg, Austria
J Invest Dermatol 137, Suppl 1:S312, 
Abstr. No 694

2018-05 IID

Doerfler P, Stuetz A, Wolff-Winiski B (2018)
Effect of exogenous platelet-derived growth factor on the proliferation of human fibroblasts in the presence of human wound exudates.
International Investigative Dermatology Meeting, May 16-19, 2018, Orlando, USA
J Invest Dermatol 138, Suppl 1:S242, 
Abstr. No 1428

2019-06 EWMA

Doerfler P, Bauer W, Goerge T, Luger T, Rappersberger K, Stingl G, Schoefmann N, Stockinger T, Stuetz A, Wolff-Winiski B (2019)
Effect of human wound exudates obtained by vacuum therapy on fibroblast proliferation and extracellular matrix formation.
EWMA 2019, 5-7 June, 2019, GothenburgSweden

2020-10c EADV

Schoefmann N, Doerfler P, Stuetz A, Wolff-Winiski B (2020)
Identification of the Poly(ADP-Ribose) Polymerase (PARP) inhibitor Veliparib as potential new drug for chronic wound therapy.
Poster at the European Academy of Dermatology and Venereology (EADV), 28-31 October, 2020

2020-10b EADV

Doerfler P, Schoefmann N, Stuetz A, Wolff-Winiski B (2020)
Screening of Wound Healing Therapeutics with an ex vivo Assay Platform using Wound Exudates from Individual Patients.
Poster at the European Academy of Dermatology and Venereology (EADV), 28-31 
October, 2020